Literature DB >> 30108768

Recent advances in the medicinal chemistry of group II and group III mGlu receptors.

Chaobin Jin1, Shutao Ma1.   

Abstract

Metabotropic glutamate receptors (mGlu receptors) belong to the G-protein-coupled receptors superfamily. They are divided into three groups, in which group II and group III belong to presynaptic receptors that negatively modulate glutamate and γ-aminobutyric acid (GABA) release when activated. In this review, we introduce not only the functions of mGlu receptors, but also the group II and group III allosteric modulators and agonists/antagonists reported over the past five years according to a classification of their structures, with a specific focus on their biological activity and selectivity. In particular, the structure of these compounds and the future directions of ideal candidates are highlighted.

Entities:  

Year:  2017        PMID: 30108768      PMCID: PMC6072351          DOI: 10.1039/c6md00612d

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  79 in total

1.  A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.

Authors:  Cyril Goudet; Bruno Vilar; Tiphanie Courtiol; Thierry Deltheil; Thomas Bessiron; Isabelle Brabet; Nadia Oueslati; Delphine Rigault; Hugues-Olivier Bertrand; Heather McLean; Hervé Daniel; Marianne Amalric; Francine Acher; Jean-Philippe Pin
Journal:  FASEB J       Date:  2012-01-05       Impact factor: 5.191

2.  Sequence and expression of a metabotropic glutamate receptor.

Authors:  M Masu; Y Tanabe; K Tsuchida; R Shigemoto; S Nakanishi
Journal:  Nature       Date:  1991-02-28       Impact factor: 49.962

3.  Cloning by functional expression of a member of the glutamate receptor family.

Authors:  M Hollmann; A O'Shea-Greenfield; S W Rogers; S Heinemann
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

4.  Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371·HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like Activity.

Authors:  Mark D Chappell; Renhua Li; Stephon C Smith; Bruce A Dressman; Eric G Tromiczak; Allie E Tripp; Maria-Jesus Blanco; Tatiana Vetman; Steven J Quimby; James Matt; Thomas C Britton; Adam M Fivush; Jeffrey M Schkeryantz; Daniel Mayhugh; Jon A Erickson; Mark G Bures; Carlos Jaramillo; Mercedes Carpintero; José Eugenio de Diego; Mario Barberis; Susana Garcia-Cerrada; José F Soriano; Stephen Antonysamy; Shane Atwell; Iain MacEwan; Bradley Condon; Christine Sougias; Jing Wang; Aiping Zhang; Kris Conners; Chris Groshong; Stephen R Wasserman; John W Koss; Jeffrey M Witkin; Xia Li; Carl Overshiner; Keith A Wafford; Wesley Seidel; Xu-Shan Wang; Beverly A Heinz; Steven Swanson; John T Catlow; David W Bedwell; James A Monn; Charles H Mitch; Paul L Ornstein
Journal:  J Med Chem       Date:  2016-12-06       Impact factor: 7.446

5.  Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM.

Authors:  Douglas J Sheffler; Cody J Wenthur; Joshua A Bruner; Sheridan J S Carrington; Paige N Vinson; Kiran K Gogi; Anna L Blobaum; Ryan D Morrison; Mitchell Vamos; Nicholas D P Cosford; Shaun R Stauffer; J Scott Daniels; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2012-04-30       Impact factor: 2.823

6.  Tricyclic thiazolopyrazole derivatives as metabotropic glutamate receptor 4 positive allosteric modulators.

Authors:  Sang-Phyo Hong; Kevin G Liu; Gil Ma; Michael Sabio; Michelle A Uberti; Maria D Bacolod; John Peterson; Zack Z Zou; Albert J Robichaud; Darío Doller
Journal:  J Med Chem       Date:  2011-07-01       Impact factor: 7.446

7.  A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease.

Authors:  Emmanuel Le Poul; Christelle Boléa; Francoise Girard; Sonia Poli; Delphine Charvin; Brice Campo; Julien Bortoli; Abdhelak Bessif; Bin Luo; Amy Jo Koser; Lisa M Hodge; Karen M Smith; Anthony G DiLella; Nigel Liverton; Fred Hess; Susan E Browne; Ian J Reynolds
Journal:  J Pharmacol Exp Ther       Date:  2012-07-11       Impact factor: 4.030

8.  Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats.

Authors:  Darren W Engers; Julie R Field; Uyen Le; Ya Zhou; Julie D Bolinger; Rocio Zamorano; Anna L Blobaum; Carrie K Jones; Satyawan Jadhav; C David Weaver; P Jeffrey Conn; Craig W Lindsley; Colleen M Niswender; Corey R Hopkins
Journal:  J Med Chem       Date:  2011-01-19       Impact factor: 7.446

9.  Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor.

Authors:  Jose María Cid; Gary Tresadern; Juan Antonio Vega; Ana Isabel de Lucas; Encarnación Matesanz; Laura Iturrino; María Lourdes Linares; Aránzazu Garcia; José Ignacio Andrés; Gregor J Macdonald; Daniel Oehlrich; Hilde Lavreysen; Anton Megens; Abdellah Ahnaou; Wilhelmus Drinkenburg; Claire Mackie; Stefan Pype; David Gallacher; Andrés A Trabanco
Journal:  J Med Chem       Date:  2012-10-16       Impact factor: 7.446

10.  Discovery of 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): a novel positive allosteric modulator of the metabotropic glutamate 2 receptor.

Authors:  José María Cid; Gary Tresadern; Guillaume Duvey; Robert Lütjens; Terry Finn; Jean-Philippe Rocher; Sonia Poli; Juan Antonio Vega; Ana Isabel de Lucas; Encarnación Matesanz; María Lourdes Linares; José Ignacio Andrés; Jesús Alcazar; José Manuel Alonso; Gregor J Macdonald; Daniel Oehlrich; Hilde Lavreysen; Abdelah Ahnaou; Wilhelmus Drinkenburg; Claire Mackie; Stefan Pype; David Gallacher; Andrés A Trabanco
Journal:  J Med Chem       Date:  2014-07-28       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.